ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Alphatec Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$10.41−0.05 (-0.48%)

Close on Oct 19, 2026

Market cap: $1.63B
P/E (TTM): –
Dividend yield: –

Dividends

Alphatec has not reported a dividend

No dividend per share appears in Alphatec's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Alphatec's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Aug 25, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATEC.

Revenue growth19.5% · median 13.9%

Gross margin70.8% · median 71.3%

Operating margin-6.0% · median 2.3%

Net margin-13.5% · median 1.9%

Company	Revenue	Growth
GMED	$3.14B	+19.7%
OFIX	$833.19M	+3.0%
ATEC	$815.05M	+19.5%
BVS	$581.85M	+3.1%
ATRC	$569.62M	+13.9%
CARL	$63.30M	+65.4%

Company

Next earnings (est.): Oct 29, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 913
Held by institutions: 73.0%
Auditor: Deloitte & Touche LLP
SEC CIK: 1350653

Advertisement
300 × 250